 vivo platelet activ beta-thalassemia major increas platelet-thromboxan urinari metabolit frequenc thromboembol event patient beta-thalassemia major TM platelet function anomali impair aggreg aggreg find shorten platelet surviv platelet hypercoagul thalassemia techniqu thin layer chromatographi purif immunoassay urinari metabolit thromboxan prostacyclin splenectom patient beta-tm non-splenectom patient beta-thalassemia intermedia TI healthi individu signific increas urinari excret alpha patient TM TI healthi control signific differ concentr metabolit TM TI patient six TM patient low dose aspirin mg/day day signific decreas urinari concentr platelet level urinari alpha vascular product alpha kidney result consist vivo product endogen platelet activ